BlackRock’s Xenon Pharmaceuticals XENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$168M Buy
5,365,327
+3,329,202
+164% +$104M ﹤0.01% 1715
2025
Q1
$68.3M Sell
2,036,125
-69,111
-3% -$2.32M ﹤0.01% 2196
2024
Q4
$82.5M Sell
2,105,236
-326
-0% -$12.8K ﹤0.01% 2159
2024
Q3
$82.9M Buy
2,105,562
+9,668
+0.5% +$381K ﹤0.01% 2164
2024
Q2
$81.7M Sell
2,095,894
-26,034
-1% -$1.02M ﹤0.01% 2126
2024
Q1
$91.3M Buy
2,121,928
+54,865
+3% +$2.36M ﹤0.01% 2073
2023
Q4
$95.2M Buy
2,067,063
+1,075,606
+108% +$49.5M ﹤0.01% 2079
2023
Q3
$33.9M Sell
991,457
-2,583
-0.3% -$88.2K ﹤0.01% 2592
2023
Q2
$38.3M Buy
994,040
+94,886
+11% +$3.65M ﹤0.01% 2600
2023
Q1
$32.2M Sell
899,154
-26,469
-3% -$947K ﹤0.01% 2671
2022
Q4
$36.5M Sell
925,623
-116,906
-11% -$4.61M ﹤0.01% 2645
2022
Q3
$37.6M Buy
1,042,529
+174,239
+20% +$6.29M ﹤0.01% 2637
2022
Q2
$26.4M Buy
868,290
+253,333
+41% +$7.71M ﹤0.01% 2877
2022
Q1
$18.8M Buy
614,957
+47,385
+8% +$1.45M ﹤0.01% 3136
2021
Q4
$17.7M Buy
567,572
+124,520
+28% +$3.89M ﹤0.01% 3287
2021
Q3
$6.77M Buy
443,052
+31,800
+8% +$486K ﹤0.01% 3787
2021
Q2
$7.66M Buy
411,252
+13,129
+3% +$244K ﹤0.01% 3679
2021
Q1
$7.13M Sell
398,123
-21,420
-5% -$383K ﹤0.01% 3707
2020
Q4
$6.45M Buy
419,543
+350,651
+509% +$5.39M ﹤0.01% 3516
2020
Q3
$763K Sell
68,892
-251
-0.4% -$2.78K ﹤0.01% 4077
2020
Q2
$866K Buy
69,143
+61,436
+797% +$769K ﹤0.01% 3992
2020
Q1
$87K Buy
+7,707
New +$87K ﹤0.01% 4303
2019
Q4
Sell
-256,667
Closed -$2.31M 5009
2019
Q3
$2.31M Sell
256,667
-1,947
-0.8% -$17.5K ﹤0.01% 3655
2019
Q2
$2.55M Sell
258,614
-8,963
-3% -$88.4K ﹤0.01% 3647
2019
Q1
$2.72M Sell
267,577
-16,131
-6% -$164K ﹤0.01% 3557
2018
Q4
$1.79M Buy
+283,708
New +$1.79M ﹤0.01% 3684